02/05/2013 01:15:55 PM EST
Mylan Says Unnamed Inventor Invalidates Merck Vytorin Patent
Posted by
Law360: Intellectual Property
Mylan Pharmaceuticals urged a Federal Circuit panel on Tuesday to invalidate Merck Sharp & Dohme Corp. patents covering the cholesterol drug Vytorin, claiming the drugmaker deceived the U.S. Patent and Trademark Office by leaving off a key co-inventor
Read More...